Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 1 (2004), Issue 3 (October)

1. Biochemical signs of impaired cobalamin status during and after radiotherapy for rectal cancer.
   Int J Radiat Oncol Biol Phys, 60(3): 807-13. [Abstract] [Full-text]
2. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer.
   Int J Radiat Oncol Biol Phys, 60(3): 794-806. [Abstract] [Full-text]
3. Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers.
   Int J Cancer, 112(5): 754-9. [Abstract] [Full-text]
4. Interactions between rat colon carcinoma cells and Kupffer cells during the onset of hepatic metastasis.
   Int J Cancer, 112(5): 793-802. [Abstract] [Full-text]
5. N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding.
   Int J Cancer, 112(5): 815-22. [Abstract] [Full-text]
6. Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia.
   Int J Cancer, 112(5): 846-53. [Abstract] [Full-text]
7. Single nucleotide polymorphism in the 5' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients.
   Int J Cancer, 112(5): 733-7. [Abstract] [Full-text]
8. Analysis of reciprocal congenic lines reveals the C3H/HeJ genome to be highly resistant to ApcMin intestinal tumorigenesis.
   Genomics, 84(5): 844-52. [Abstract] [Full-text]
9. Cell cycle-related signaling pathways modulated by peripheral benzodiazepine receptor ligands in colorectal cancer cells.
   Biochem Biophys Res Commun, 324(2): 878-86. [Abstract] [Full-text]
10. The potent colon carcinogen, 1,2-dimethylhydrazine induces mutations primarily in the colon.
    Mutat Res, 564(1): 1-7. [Abstract] [Full-text]
11. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.
    Hum Mutat, 24(5): 370-80. [Abstract] [Full-text]
12. Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy.
    J Infect Dis, 190(9): 1685-91. [Abstract] [Full-text]
13. Nitric oxide signaling in colon cancer chemoprevention.
    Mutat Res, 555(1): 107-19. [Abstract] [Full-text]
14. Anticipated reactions to genetic testing for hereditary non-polyposis colorectal cancer susceptibility.
    Clin Genet, 66(5): 437-44. [Abstract] [Full-text]
15. Phospholipids reduce the intraperitoneal adhesion of colonic tumor cells in rats and adhesion on extracellular matrix in vitro.
    Int J Colorectal Dis, 19(6): 525-32. [Abstract] [Full-text]
16. Comparison of EORTC quality of life core questionnaire (EORTC-QLQ-C30) and gastrointestinal quality of life index (GIQLI) in patients undergoing elective colorectal cancer resection.
    Int J Colorectal Dis, 19(6): 554-60. [Abstract] [Full-text]
17. Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine.
    Int J Colorectal Dis, 19(6): 599-602. [Abstract] [Full-text]
18. Prognostic significance of microsatellite instability in sporadic colorectal cancer.
    Int J Colorectal Dis, 19(6): 533-7. [Abstract] [Full-text]
19. Ileocecal reservoir reconstruction after total mesorectal excision: functional results of the long-term follow-up.
    Int J Colorectal Dis, 19(6): 574-9. [Abstract] [Full-text]
20. Does any lower gastrointestinal bleeding in patients suffering from hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu) necessitate a full colonic visualization?
    Int J Colorectal Dis, 19(6): 595-8. [Abstract] [Full-text]
21. Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patients.
    Int J Colorectal Dis, 19(6): 545-53. [Abstract] [Full-text]
22. Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome.
    Int J Colorectal Dis, 19(6): 580-5. [Abstract] [Full-text]
23. Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.
    Int J Colorectal Dis, 19(6): 518-24. [Abstract] [Full-text]
24. Endoscopic transanal resection using the urological resectoscope in the management of patients with rectal villous adenomas.
    Int J Colorectal Dis, 19(6): 569-73. [Abstract] [Full-text]
25. BAX and caspase-5 frameshift mutations and spontaneous apoptosis in colorectal cancer with microsatellite instability.
    Int J Colorectal Dis, 19(6): 538-44. [Abstract] [Full-text]
26. Geno- and pheno-typic characterization in ten patients with double-primary gastric and colorectal adenocarcinomas.
    Int J Colorectal Dis, 19(6): 561-8. [Abstract] [Full-text]
27. Vascular endothelial growth factor in colorectal cancer.
    Int J Colorectal Dis, 19(6): 510-7. [Abstract] [Full-text]
28. Tissue distribution, stability, and pharmacokinetics of Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in human colon carcinoma COLO205 tumor-bearing nude mice.
    Drug Metab Dispos, 32(11): 1230-8. [Abstract] [Full-text]
29. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
    Biochem Biophys Res Commun, 324(3): 999-1003. [Abstract] [Full-text]
30. Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cells.
    Cancer Lett, 215(2): 159-66. [Abstract] [Full-text]
31. The candidate oncogene ZNF217 is frequently amplified in colon cancer.
    J Pathol, 204(3): 282-8. [Abstract] [Full-text]
32. CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation.
    J Pathol, 204(3): 289-95. [Abstract] [Full-text]
33. Expression and clinical significance of CD44V5 and CD44V6 in resectable colorectal cancer.
    J Cancer Res Clin Oncol, 130(11): 679-86. [Abstract] [Full-text]
34. High-grade dysplasia associated with fundic gland polyposis in a familial adenomatous polyposis patient, with special reference to APC mutation profiles.
    Mod Pathol, 17(11): 1421-6. [Abstract] [Full-text]
35. Commuting physical activity and risk of colon cancer in Shanghai, China.
    Am J Epidemiol, 160(9): 860-7. [Abstract] [Full-text]
36. CYP1A1, cigarette smoking, and colon and rectal cancer.
    Am J Epidemiol, 160(9): 842-52. [Abstract] [Full-text]
37. Influence of proinflammatory cytokines on the adhesion of human colon carcinoma cells to lung microvascular endothelium.
    Int J Cancer, 112(6): 943-50. [Abstract] [Full-text]
38. JTE-522, a selective COX-2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: a vascular cast model study.
    Int J Cancer, 112(6): 920-6. [Abstract] [Full-text]
39. Treatment of locally recurrent rectal cancer, results and prognostic factors.
    Eur J Surg Oncol, 30(9): 954-8. [Abstract] [Full-text]
40. Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression.
    Eur J Surg Oncol, 30(9): 948-53. [Abstract] [Full-text]
41. Preincisional intravenous pentoxifylline attenuating perioperative cytokine response, reducing morphine consumption, and improving recovery of bowel function in patients undergoing colorectal cancer surgery.
    Anesth Analg, 99(5): 1465-71; table of contents. [Abstract] [Full-text]
42. Neutrophil-mediated formation of carcinogenic N-nitroso compounds in an in vitro model for intestinal inflammation.
    Toxicol Lett, 154(3): 175-82. [Abstract] [Full-text]
43. What pathologic features influence survival in patients with local residual tumor after resection of colorectal cancer?
    J Am Coll Surg, 199(5): 680-6. [Abstract] [Full-text]
44. Standardized approach to laparoscopic right colectomy: outcomes in 70 consecutive cases.
    J Am Coll Surg, 199(5): 675-9. [Abstract] [Full-text]
45. COX-2 inhibition as a tool to treat and prevent colorectal cancer.
    Crit Rev Oncol Hematol, 52(2): 81-101. [Abstract] [Full-text]
46. High expression of endothelial cell nitric oxide synthase in peritumoral microvessels predicts increased disease-free survival in colorectal cancer.
    Cancer Lett, 216(1): 109-14. [Abstract] [Full-text]
47. The clinical features of rectal cancers with high-frequency microsatellite instability (MSI-H) in Japanese males.
    Cancer Lett, 216(1): 55-62. [Abstract] [Full-text]
48. Exhaustive physical exercise increases the number of colonic preneoplastic lesions in untrained rats treated with a chemical carcinogen.
    Cancer Lett, 216(1): 31-4. [Abstract] [Full-text]
49. Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-induced apoptosis.
    J Biol Chem, 279(44): 46113-21. [Abstract] [Full-text]
50. APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia.
    Exp Mol Pathol, 77(3): 193-200. [Abstract] [Full-text]
51. Current techniques and results of liver resection for colorectal liver metastases.
    Br Med Bull, 70: 87-104. [Abstract] [Full-text]
52. Serrated adenoma of the duodenum.
    J Clin Pathol, 57(11): 1219-21. [Abstract] [Full-text]
53. Histopathological assessment of lymph nodes in colorectal carcinoma: does triple levelling detect significantly more metastases?
    J Clin Pathol, 57(11): 1165-7. [Abstract] [Full-text]
54. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival.
    J Clin Pathol, 57(11): 1160-4. [Abstract] [Full-text]
55. Psychological distress in couples dealing with colorectal cancer: gender and role differences and intracouple correspondence.
    Br J Health Psychol, 9: 465-78. [Abstract] [Full-text]
56. Allelic imbalance of APAF-1 locus at 12q23 is related to progression of colorectal carcinoma.
    Oncogene, 23(50): 8292-300. [Abstract] [Full-text]
57. Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.
    J Clin Oncol, 22(21): 4410-7. [Abstract] [Full-text]
58. Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH.
    Nucleic Acids Res, 32(19): e146. [Abstract] [Full-text]
59. Versican and hyaluronan expression in canine colonic adenomas and carcinomas: relation to malignancy and depth of tumour invasion.
    J Comp Pathol, 131(4): 259-70. [Abstract] [Full-text]
60. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
    Br J Cancer, 91(9): 1718-25. [Abstract] [Full-text]
61. Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis.
    Br J Cancer, 91(9): 1711-7. [Abstract] [Full-text]
62. Comparison of cancer survival in UK and Australia: rates are higher in Australia for three major sites.
    Br J Cancer, 91(9): 1663-5. [Abstract] [Full-text]

© 2004-2010 Colorectal Cancer Research Today. All Rights Reserved.